Mr. Wook-Je Cho is the President, CEO & Executive Director at Yuhan Corporation. He was Head of the Planning and Management Division at Yuhan Corporation and served as its Head of Pharmaceutical Business C...

Board Members

Name	Position	Tenure	Compensation	Ownership
Wook-Je Cho	President	no data	no data	0.025% ₩ 2.5b
Yeul-Hong Kim	Executive Director	less than a year	no data	0.0068% ₩ 676.3m
Jung-Hee Lee	Non-Executive Director	no data	no data	0.078% ₩ 7.7b
Sung Gil Chi	Independent Outside Director	no data	no data	no data
Dong-Jin Park	Independent Outside Director	no data	no data	0.0027% ₩ 267.9m
Jun-Cheol Kim	Independent Outside Director	4yrs	no data	no data
Young-Jae Shin	Independent Outside Director	4yrs	no data	no data

4.0yrs

Average Tenure

69yo

Average Age

Experienced Board: A000100's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 08:52
End of Day Share Price	2025/01/10 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yuhan Corporation is covered by 37 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Young-Ah Han	BofA Global Research
Seohyun Lee	Citigroup Inc
Hyonseok Kim	CLSA

Yuhan Management

Management criteria checks 1/4

Key information

Recent management updates

Insufficient new directors

Yuhan Corporation, Annual General Meeting, Mar 19, 2021

Recent updates

Calculating The Intrinsic Value Of Yuhan Corporation (KRX:000100)

Upcoming dividend of ₩429 per share

Now 21% overvalued

Price target increased by 8.2% to ₩132,214

Dividend of ₩429 announced

Yuhan Corporation (KRX:000100) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Is Yuhan (KRX:000100) Using Too Much Debt?

Price target increased by 8.1% to ₩110,188

Price target increased by 7.9% to ₩108,412

Investor sentiment improves as stock rises 17%

Estimating The Intrinsic Value Of Yuhan Corporation (KRX:000100)

Investor sentiment improves as stock rises 44%

Subdued Growth No Barrier To Yuhan Corporation (KRX:000100) With Shares Advancing 41%

Price target increased by 7.1% to ₩99,222

Investor sentiment deteriorates as stock falls 15%

Now 20% undervalued

Investor sentiment improves as stock rises 15%

Yuhan Corporation's (KRX:000100) Price In Tune With Earnings

Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate

Investor sentiment improves as stock rises 19%

Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem

Consensus revenue estimates increase by 28%

Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly

Now 22% overvalued after recent price rise

Full year 2023 earnings released: EPS: ₩1,815 (vs ₩1,267 in FY 2022)

Yuhan Corporation's (KRX:000100) P/E Is Still On The Mark Following 26% Share Price Bounce

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 21% undervalued

Upcoming dividend of ₩381 per share at 0.6% yield

Consensus EPS estimates increase by 37%, revenue downgraded

Investor sentiment deteriorates as stock falls 23%

Now 24% undervalued

Price target increased by 7.8% to ₩80,222

First quarter 2023 earnings released: EPS: ₩311 (vs ₩222 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 21% undervalued after recent price drop

Upcoming dividend of ₩381 per share

Consensus EPS estimates fall by 11%

Now 20% undervalued

Full year 2021 earnings: EPS and revenues miss analyst expectations

Yuhan Corporation (KOSE:A000100) announces an Equity Buyback for KRW 20,000 million worth of its shares.

Upcoming dividend of ₩381 per share

Third quarter 2021 earnings released: EPS ₩470 (vs ₩464 in 3Q 2020)

First quarter 2021 earnings released: EPS ₩315 (vs ₩1,768 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS ₩2,943 (vs ₩610 in FY 2019)

New 90-day low: ₩60,700

Yuhan Corporation, Annual General Meeting, Mar 19, 2021

New 90-day high: ₩75,100

New 90-day high: ₩75,100

New 90-day high: ₩72,300

Price target raised to ₩72,704

Price target raised to ₩67,579

Yuhan Corporation and Sorrento Therapeutics, Inc. Announces Completion of Phase 1 Clinical Study of Anti-PD-L1 Antibody IMC-001

New 90-day high: ₩72,000

Price target raised to ₩63,148

CEO

Tenure